公司概覽
業務類別 --
業務概覽 Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medicalsegment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such asvials and syringes. Nipro generates the majority of its revenue in Japan.
公司地址 3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
電話號碼 +81 663722331
傳真號碼 +81 663750669
公司網頁 http://www.nipro.co.jp
員工數量 30461
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Tsuyoshi Yamazaki Director and President -- 25/06/2025
Mr. Hideto Nakamura Director, General Manager, General Affairs and Human Resources Department and General Manager, Governance Supervisory Department -- 25/06/2025
Mr. Kimihito Minoura Director, Managing Director, General Manager, Business Promotion Department, General Manager, Business Administration Headquarters and General Manager of New Business Development Division -- 25/06/2025
Mr. Taku Nikaido Director, Executive Officer, Executive General Manager, Medical Instruments Development and Technical Sales Headquarters and Executive General Manager, Medical Instruments Development and Technical Sales Headquarters, Global Business Division -- 25/06/2025
Mr. Goichi Miyazumi Director, Senior Executive Officer and Deputy Division Manager, Global Business Division -- 25/06/2025
Mr. Kaname Sadahiro Director, Senior Executive Officer, Executive General Manager, Global Product Development and Sales Headquarters, Global Business Division, General Manager, Dialysis and Blood Purification Product Development and Technical Sales Department and General Man -- 25/06/2025
Mr. Atsushi Yoneda Director, Executive Officer and General Manager, Operation Department, Production Technology Center -- 25/06/2025
Mr. Hideyuki Nishisako Director and Executive Officer -- 25/06/2025
Mr. Takehito Yogo Director, Senior Managing Director and General Manager, Corporate Planning Headquarters, Administrative Control -- 25/06/2025
Mr. Yasushi Ohyama Director, Managing Director and General Manager, Vascular Division -- 25/06/2025
Mr. Kenichi Nishida Director, Managing Director and General Manager, Pharmaceutical Manufacturing and Administration Division -- 25/06/2025
 
董事會成員
董事會 職務 更新日期
Mr. Yoshihiko Sano Chairman of the Board 25/06/2025
Ms. Yoshiko Tanaka Independent Director 25/06/2025
Mr. Tsuyoshi Yamazaki Director and President 25/06/2025
Mr. Toshiaki Hattori Independent Director 25/06/2025
Mr. Toshikazu Yoshimori Independent Director 25/06/2025
Mr. Hideto Nakamura Director, General Manager, General Affairs and Human Resources Department and General Manager, Governance Supervisory Department 25/06/2025
Mr. Kimihito Minoura Director, Managing Director, General Manager, Business Promotion Department, General Manager, Business Administration Headquarters and General Manager of New Business Development Division 25/06/2025
Mr. Taku Nikaido Director, Executive Officer, Executive General Manager, Medical Instruments Development and Technical Sales Headquarters and Executive General Manager, Medical Instruments Development and Technical Sales Headquarters, Global Business Division 25/06/2025
Mr. Goichi Miyazumi Director, Senior Executive Officer and Deputy Division Manager, Global Business Division 25/06/2025
Ms. Yuka Kushida Independent Director 25/06/2025
Mr. Yasuhiko Imaizumi Independent Director 25/06/2025
Mr. Kaname Sadahiro Director, Senior Executive Officer, Executive General Manager, Global Product Development and Sales Headquarters, Global Business Division, General Manager, Dialysis and Blood Purification Product Development and Technical Sales Department and General Man 25/06/2025
Mr. Atsushi Yoneda Director, Executive Officer and General Manager, Operation Department, Production Technology Center 25/06/2025
Mr. Hideyuki Nishisako Director and Executive Officer 25/06/2025
Ms. Yoshiko Shimamori Independent Director 25/06/2025
Mr. Takehito Yogo Director, Senior Managing Director and General Manager, Corporate Planning Headquarters, Administrative Control 25/06/2025
Mr. Yasushi Ohyama Director, Managing Director and General Manager, Vascular Division 25/06/2025
Mr. Kenichi Nishida Director, Managing Director and General Manager, Pharmaceutical Manufacturing and Administration Division 25/06/2025
 
所屬ETF (更新日期: 07/03/2026 04:33)
代號 名稱 佔比% 持有日期
AVDVAvantis International Small Cap Val ETF2.14%28/02/2026
IEFAiShares Core MSCI EAFE ETF0.61%28/02/2026
SCZiShares MSCI EAFE Small-Cap ETF0.38%28/02/2026
SCHFSchwab International Equity ETF™0.21%28/02/2026
DISVDimensional International Sm Cp Val ETF0.21%27/02/2026
VEUVanguard FTSE All-Wld ex-US ETF0.20%31/01/2026
FNDCSchwab Fundamental International SmEqETF0.18%28/02/2026
DFISDimensional International Small Cap ETF0.17%27/02/2026
AVDEAvantis International Equity ETF0.17%28/02/2026
DXJWisdomTree Japan Hedged Equity ETF0.16%27/02/2026
DFICDimensional International Core Eq 2 ETF0.15%27/02/2026
IXUSiShares Core MSCI Total Intl Stk ETF0.13%28/02/2026
IDEViShares Core MSCI Intl Dev Mkts ETF0.11%28/02/2026
SPDWState Street® SPDR® Ptf Dev Wld exUS ETF0.11%27/02/2026
DFAXDimensional World ex US Core Eq 2 ETF0.08%27/02/2026
DFAIDimensional International Cr Eq Mkt ETF0.07%27/02/2026
VTVanguard Total World Stock ETF0.06%31/01/2026
GWXState Street® SPDR® S&P® Intl Sm Cp ETF0.03%27/02/2026
IPACiShares Core MSCI Pacific ETF0.03%28/02/2026
IMFLInvesco Intl Dev Dynmc Mltfctr ETF0.02%27/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.